Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15160668 | 0.80 | MCL1 (0.41) | CNR2 | |
| SCHEMBL14520490 | 0.78 | FAAH (0.35) | — | |
| SCHEMBL24979274 | 0.77 | SLC6A5 (0.37) | — | |
| SCHEMBL13407578 | 0.77 | CACNA1H (0.36) | CNR2 | |
| SCHEMBL12300506 | 0.76 | PGK1 (0.40) | — | |
| SCHEMBL16710792 | 0.74 | CNR2 (0.34) | CNR2 | |
| Hydrogen Peroxide SCHEMBL5680213 | 0.73 | NAALAD2 (0.38) | — | |
| SCHEMBL27672 | 0.73 | NAALAD2 (0.38) | — | |
| SCHEMBL786277 | 0.73 | NAALAD2 (0.38) | — | |
| SCHEMBL27673 | 0.73 | NAALAD2 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026627-A1 | Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery | VACCITECH NORTH AMERICA, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2022086853-A1 | STAR POLYMER DRUG CONJUGATES | AVIDEA TECHNOLOGIES, INC. (US) | 2022-04-28 | — | — | WO | disclosed |
| WO-2020214858-A1 | COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY | AVIDEA TECHNOLOGIES, INC. (US) | 2020-10-22 | — | — | WO | disclosed |
| US-9289510-B2 | Polymeric drug delivery conjugates and methods of making and using thereof | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2016-03-22 | — | — | US | disclosed |
| US-20130156722-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026627-A1 | Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery | TNFSF10, SELPLG, FCGRT | CNR2 1548/4885 |
| US-20130156722-A1 | POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF | CD44, MMP7, MMP26 | CNR2 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.